Bearing Point Capital LLC Acquires 3,637 Shares of Danaher Corporation $DHR

Bearing Point Capital LLC grew its holdings in Danaher Corporation (NYSE:DHR) by 9.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 40,909 shares of the conglomerate’s stock after acquiring an additional 3,637 shares during the quarter. Danaher accounts for approximately 1.5% of Bearing Point Capital LLC’s investment portfolio, making the stock its 18th biggest position. Bearing Point Capital LLC’s holdings in Danaher were worth $9,365,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. JPL Wealth Management LLC bought a new stake in shares of Danaher in the third quarter valued at about $25,000. Elevated Capital Advisors LLC bought a new stake in shares of Danaher in the fourth quarter valued at about $26,000. WFA of San Diego LLC bought a new stake in shares of Danaher in the second quarter valued at about $26,000. ANTIPODES PARTNERS Ltd bought a new stake in shares of Danaher in the third quarter valued at about $27,000. Finally, Financial Life Planners bought a new stake in shares of Danaher in the third quarter valued at about $32,000. Institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently commented on DHR shares. Evercore boosted their price target on Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a research note on Tuesday, April 21st. Rothschild & Co Redburn set a $205.00 price target on Danaher in a research note on Friday, April 17th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Danaher in a research note on Friday, March 27th. Guggenheim dropped their price target on Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Finally, Royal Bank Of Canada started coverage on Danaher in a research note on Thursday, May 14th. They issued an “outperform” rating and a $200.00 price target for the company. Twenty research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $238.24.

Danaher Stock Up 1.2%

Shares of NYSE DHR opened at $182.73 on Friday. The company has a market cap of $129.33 billion, a price-to-earnings ratio of 35.34, a PEG ratio of 2.44 and a beta of 0.81. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The stock has a 50-day moving average price of $182.11 and a two-hundred day moving average price of $207.48.

Danaher (NYSE:DHR) last posted its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The firm had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.88 earnings per share. As a group, analysts forecast that Danaher Corporation will post 8.43 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. Danaher’s dividend payout ratio is 30.95%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.